Institut Coeur-Poumon, Pôle d'Hématologie-Transfusion, CHU
Institut Coeur-Poumon, Pôle d'Hématologie-Transfusion, CHU
Lille, France1 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| UPLC-MS/MS Monitoring of Emicizumab Therapy | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hemic and Lymphatic Diseases, blood coagulation disease, coagulation protein disease, hematologic disorder, hemophilia A, hemorrhagic disease, hereditary disease, inherited blood coagulation disorder | Active, not recruiting | Not stated | 2026-05-20 | NCT04472169 |